Avalyn Pharma Inc (AVLN) Income Statement

7 Followers

Avalyn Pharma Inc Income Statement

Last quarter (Q2 2026), Avalyn Pharma Inc's total revenue was $0.00, a decrease of ― from previous quarter. In Q2, Avalyn Pharma Inc's net income was $-28.93M. See Avalyn Pharma Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25
Total Revenue	$ 0.00
Gross Profit	$ 0.00
Operating Expenses	$ 91.29M
Depreciation and Amortization	$ 42.00K
EBITDA	$ -91.25M
Operating Income	$ -91.29M
Other Income/Expenses	$ 6.09M
Pretax Income	$ -85.20M
Net Income	$ -85.20M
Per Share Metrics
Basic EPS	$ -2.04
Diluted EPS	$ -2.04
Weighted Average Shares Outstanding	41.81M
Weighted Average Shares Outstanding (Diluted)	41.81M

Currency in USD

Avalyn Pharma Inc (AVLN) Income Statement

Avalyn Pharma Inc Income Statement

Avalyn Pharma Inc Earnings and Revenue History